Resmed Inc. buy Needham & Company LLC
Start price
06.09.23
/
50%
€143.10
Target price
06.09.24
-
Performance (%)
55.49%
End price
07.09.24
€222.50
Summary
This prediction ended on 07.09.24 with a price of €222.50. With a performance of 55.49% the BUY prediction by Needham___Company_LL was a big success. A total of €1.82 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.781% | 2.781% | 5.805% |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten